Role of bone-forming agents in the management of osteoporosis

被引：27
|
作者：
McClung, Michael R. [1 ,2 ]
机构：
[1] Oregon Osteoporosis Ctr, Portland, OR 97225 USA
[2] Australian Catholic Univ, Mary MacKillop Ctr Hlth Res, Melbourne, Vic, Australia
来源：
AGING CLINICAL AND EXPERIMENTAL RESEARCH | 2021年 / 33卷 / 04期
基金：
美国国家卫生研究院;
关键词：
Osteoporosis; Osteoanabolic; Abaloparatide; Romosozumab; Teriparatide; Sequence;
D O I：
10.1007/s40520-020-01708-8
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
Recent evidence confirms the superiority of osteoanabolic therapy compared to anti-remodeling drugs for rapid improvement in bone density and fracture risk reduction, providing strong justification for the use of these anabolic agents as the initial therapy in high-risk patients, to be followed by anti-remodeling therapy. This review will highlight the results of recent studies and define the current status of osteoanabolic therapy for osteoporosis.
引用
收藏
页码：775 / 791
页数：17
相关论文
共 50 条
  • [21] WHAT CAN WE EXPECT FROM BONE FORMING AGENTS IN THE MANAGEMENT OF OSTEOPOROSIS?
    Ferrari, S.
    OSTEOPOROSIS INTERNATIONAL, 2017, 28 : S43 - S44
  • [22] Treatment of postmenopausal osteoporosis with bone-forming and antiresorptive treatments: Combined and sequential approaches
    Langdahl, Bente
    BONE, 2020, 139
  • [23] Benign bone-forming tumors
    Heuck, A
    Stäbler, A
    Wörtler, K
    Steinborn, M
    RADIOLOGE, 2001, 41 (07): : 540 - 547
  • [24] Transplantation of bone-forming cells
    Mankani, MH
    Robey, PG
    ENDOCRINOLOGIST, 1998, 8 (06): : 459 - 467
  • [25] The diverse origin of bone-forming osteoblasts
    Mizoguchi, Toshihide
    Ono, Noriaki
    JOURNAL OF BONE AND MINERAL RESEARCH, 2021, 36 (08) : 1432 - 1447
  • [26] Recommendations for the optimal use of bone forming agents in osteoporosis
    Veronese, Nicola
    Briot, Karine
    Guanabens, Nuria
    Albergaria, Ben Hur
    Alokail, Majed
    Al-Daghri, Nasser
    Bemden, Angie Botto-van
    Bruyere, Olivier
    Burlet, Nansa
    Cooper, Cyrus
    Curtis, Elizabeth M.
    Ebeling, Peter R.
    Halbout, Philippe
    Hesse, Eric
    Hiligsmann, Mickael
    Camargos, Bruno Muzzi
    Harvey, Nicholas C.
    Perez, Adolfo Diez
    Radermecker, Regis Pierre
    Reginster, Jean-Yves
    Rizzoli, Rene
    Siggelkow, Heide
    Cortet, Bernard
    Brandi, Maria Luisa
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2024, 36 (01)
  • [27] THE IMPORTANCE OF BONE FORMING AGENTS IN THE TREATMENT OF SEVERE OSTEOPOROSIS
    Seeman, E.
    Ferrari, S.
    OSTEOPOROSIS INTERNATIONAL, 2019, 30 : S47 - S48
  • [28] OSTEOCLAST FORMATION FROM MONONUCLEAR PHAGOCYTES - ROLE OF BONE-FORMING CELLS
    BURGER, EH
    VANDERMEER, JWM
    NIJWEIDE, PJ
    JOURNAL OF CELL BIOLOGY, 1984, 99 (06): : 1901 - 1906
  • [29] Skeletal benign bone-forming lesions
    Cerase, A
    Priolo, F
    EUROPEAN JOURNAL OF RADIOLOGY, 1998, 27 : S91 - S97
  • [30] Androgen receptors in bone-forming tissue
    Noble, B
    Routledge, J
    Stevens, H
    Hughes, I
    Jacobson, W
    HORMONE RESEARCH, 1999, 51 (01) : 31 - 36
12345